Business Ideas

Glenmark Generics files IPO prospectus with Sebi

Drug maker Glenmark Pharmaceuticals today said its subsidiary Glenmark Generics has filed the draft prospectus with marker regulator Securities and Exchange Board of India (SebiI) for an initial public offer (IPO). - Cost audit should be included in Clause 49: Panel - Bharati expects nod for Great Offshore open offer soon - An exchange of their own - Bharati Shipyard mulls Rs 200-cr capex over two years - Sahara realty arm files IPO prospectus, to raise Rs 3,450 cr - Sebi wants listed firms to provide sufficient info to market "Glenmark Generics, has, on September 30, filed the draft red herring prospectus (DRHP) with Sebi for an Initial Public Offer," Glenmark Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE). Drug maker did not disclose any further details about the public issue.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
The move is appropriate and adequate, says govt
Even as some sections of industry found the 75 basis points (bps) increase in the cash reserve ratio (CRR) more than expected, the government commended the Reserve Bank of India (RBI) for the “right move” and said it would not result in an immediate increase in interest rates. It said the Reserve Bank had aptly acknowledged the need for paying attention to inflation as well as growth.
Popular Articles
payday loan lenders

No Impact of Dubai crisis on India: Zoellick
The World Bank chief meets top policy makers.

Rising tide
Autism awareness is growing, as the increasing number of cases shows

© Copyright 2009